Nat Rev Endocrinol 8(12):728742 Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS et al (2015) Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial
The dosing regimens for these medications reflect their different pharmacokinetic properties and tolerability profiles
Our mission is to simplify this process through empathy and science-backed expertise
Diets help, but patients know, if you were losing weight, I hate to say it, they probably wouldnt be going for the GLP-1s typically
These effects include: Disclosed Side Effects: Inflammation of the pancreas (pancreatitis) Vision changes Kidney failure and other kidney problems Allergic reactions Additional Potential Dangers: Gallstones Acute gallbladder disease (cholecystitis) Thyroid tumors or thyroid cancer Diabetic retinopathy Hypoglycemia (low blood sugar) Gastroparesis (stomach paralysis) It is important for individuals to understand these potential risks and discuss them with a healthcare professional
SD, 15 mmHg s) after administration of GLP1
